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Background: Health-related quality of life (HRQoL) is gaining importance as a valuable outcome measure in oral
cancer area. The aim of this study was to assess the general and oral HRQoL of oral and oropharyngeal cancer
patients 6 or more months after treatment and compare them with a population free from this disease.
Methods: A cross-sectional study was carried out with patients treated for oral cancer at least 6 months post-treatment
and a gender and age group matched control group. HRQoL was measured with the 12-Item Short Form Health Survey
(SF-12); oral HRQoL (OHRQoL) was evaluated using the Oral Health Impact Profile (OHIP-14) and the Oral Impacts on
Daily Performances (OIDP). Multivariable regression models assessed the association between the outcomes (SF-12,
OHIP-14 and OIDP) and the exposure (patients versus controls), adjusting for sex, age, social class, functional tooth units
and presence of illness.
Results: For patients (n = 142) and controls (n = 142), 64.1% were males. The mean age was 65.2 (standard deviation
(sd): 12.9) years in patients and 67.5 (sd: 13.7) years in controls. Patients had worse SF-12 Physical Component Summary
scores than controls even in fully the adjusted model [β-coefficient = −0.11 (95% CI: −5.12-(−0.16)]. The differences in SF-12
Mental Component Summary were not statistically significant. Regarding OHRQoL patients had 11.63 (95% CI: 6.77-20.01)
higher odds for the OHIP-14 and 21.26 (95% CI: 11.54-39.13) higher odds for OIDP of being in a worse category of
OHRQoL compared to controls in the fully adjusted model.
Conclusion: At least 6 months after treatment, oral cancer patients had worse OHRQoL, worse physical
HRQoL and similar psychological HRQoL than the general population.
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Incidence rates have increased for oral cavity and
oropharyngeal cancers in recent years [1]. Improvement
in the treatments has resulted in a decrease in mortality
[2] and consequently more patients than ever before are
living with the sequelaes of the illness [3]. These
sequelaes could affect their quality of life [4]. Thus, the
measurement of health-related quality of life (HRQoL) is* Correspondence: rbarrios@ugr.es
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unless otherwise stated.gaining importance as a valuable outcome measure,
particularly in the oral cancer area.
Health-related quality of life is a concept that reflects
a subjective measurement of health status, commonly
assessed by generic or disease-specific questionnaires.
Generic questionnaires provide valuable information by
interpreting functional status in the broader scope of the
patient’s life [5]. Moreover, as they are not specific for
oral cancer, they potentially allow comparisons with
populations free from this disease. However, due to the
complex anatomy of the oral cavity it is desirable to
complement generic HRQoL measures with the use of
specific oral health-related quality of life (OHRQoL)This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sing the impact of oral conditions on daily life [6].
A relevant question in oral cancer patients is to assess
the degree to which patients adapt to the treatment
effects and recover their habitual lifestyle post-treatment.
Long-term HRQoL assessment including a comparison
group would aid to answer this question and would
improve the interpretations of findings [7]. Relevant
studies in homogeneous samples of oral and oropharyngeal
cancer patients have been inconclusive. Some found that
patients had lower scores (worse HRQoL) [8,9] and others
found similar scores or even higher scores (better HRQoL)
[10-13] compared to reference values. Moreover, most
studies compared the results with population norms and
only one, focused on physiological problems, used a control
group [11].
The aim of this study was to assess the general and
oral HRQoL of oral and oropharyngeal cancer patients
in Granada, Spain, 6 or more months after treatment




A sex and age group frequency matching study was
conducted from January 2011 to January 2014. The
study base was the population of Granada, a province
in Southern Spain. All people diagnosed with oral
cancer were referred to the Virgen de las Nieves University
Hospital. Therefore, the patients of our study were
selected from the Department of Maxillofacial Surgery of
that hospital. Inclusion criteria for participation in the
study were: patients treated for oral or oropharyngeal
cancer, treatment has finalized at least six months before
the recruitment to the study and the patients were free
from recurrence of the disease. In such a study, the
controls should come from the same population than the
cases. Therefore, the controls were selected from different
settings in Granada (social centers, geriatric centers and
companions of hospital patients) with the following
inclusion criteria: not diagnosed for oral cancer and
belonging to one of the sample strata (sex and age group).
Cases and controls were grouped into sex and age
group strata that were matched to have the same
frequency. We only considered age and sex in the
frequency matching to avoid an excessive numbers
of strata in the sampling procedure which could
make it impractical. Other relevant variables, such as
sociodemographic factors, were instead considered in
the statistical analysis as confounding factors and were
adjusted for in multivariable associations. A total of 145
cases and 146 controls fulfilled the inclusion/exclusion
criteria and were initially selected. Of them, 3 cases and 4
controls did not accept to participate in the study, giving142 cases (97.9% acceptance rate) and 142 controls (97.3%
acceptance rate) for the analysis.
Our sample sizes, 142 cases and 142 controls, is sufficient
to detect, with a significance level α = 0.05 and power =
80% (β = 0.20), a standardized difference of 0.3 in the
outcome between patients and controls, which is between
small (0.2) and moderate (0.5) (according to Cohen’s
scale [14]).
The study was approved by the Ethics Committee of
the University of Granada and signed an informed
consent was obtained from each participant.
HRQoL and OHRQoL measures were treated as the
outcome variables, study group (patients or controls) as
the main exposure and sex, age, social class, presence of
illness (comorbidities) and functional tooth units as
covariates. Functional posterior tooth units were defined
as pairs of occluding natural, restored or fixed prosthetic
postcanine teeth (molars = 2 units; bicuspids = 1 unit)
[15]. Functional anterior tooth units were defined as
pairs of occluding natural, restored or fixed prosthetic
precanine teeth (each tooth = 1 unit). Moreover, specific
data of the tumor and treatment (tumor location, clinical
stage, date of treatment completion and type of treatment)
was collected for the patients.
Measurement of HRQoL
The 12-Item Short Form Health Survey was used to
evaluate HRQoL. The 12-Item Short Form Health
Survey (SF-12) is a reduced version of one the most
commonly used general questionnaire, the 36-Item Short
Form Health Survey (SF-36). The version 2 of SF-12 is a
useful tool with the advantages of its brevity versus
SF-36 and the possibility of calculating the 8 original
dimensions versus the version 1 [16,17]. This validated
instrument [18] contains 12 ítems with 3- or 5-point
Likert scales. These items result in 8 dimensions: Physical
Functioning, Role Physical, Bodily Pain, General Health,
Vitality, Social Functioning, Role Emotional, and Mental
Health. Two summary scores, Physical Component
Summary and Mental Component Summary, are calculated
from these dimensions.
The derivation of SF-12 scores followed established
procedures [19]. First, we calculated the scores of the 8
dimensions and transformed them to a 1–100 scale;
then, the scores were standardized and finally a lineal
transformation was done. The lineal transformation was
done taking the values 50 and 10 as sample estimate of
the mean and standard deviation respectively of the
reference general population. Computations of the
aggregate summary components consist of multiplying
each of eight standardized dimensions by its respective
physical or mental factor score coefficient, and then
summing the eight products. The last step also involves
transforming the aggregate physical and mental summary
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specific method for the calculation using theSF-12
reference standards for the Spanish population [16].
Higher scores indicate better quality of life.Measurement of OHRQoL
OHRQoL was assessed through two widely used relevant
generic measures: the Oral Health Impact Profile
(OHIP-14) and the Oral Impacts on Daily Performances
(OIDP). The Oral Health Impact Profile (OHIP-14)
comprises 14 items that explore seven dimensions of
impact: functional limitation, physical pain, psychological
discomfort, physical disability, psychological disability,
social disability and handicap. The participants respond to
each item according to the frequency of the impact on a
5-point Likert scale (ranging from 0 to 4): never, hardly
ever, occasionally, fairly often, and very often [20]. The
additive score (OHIP-A) scoring method was used where
the total score was calculated summing the item
codes for the 14 items. The OHIP-14 extent was calculated
as the number of individual items affected by impacts
occasionally or more frequently.
The Oral Impacts on Daily Performances (OIDP)
index assesses the impact of oral conditions on eight daily
performances: eating, speaking, cleaning teeth, carrying
out major work or role, social contact, relaxing/sleeping,
smiling, and emotional state. It evaluates the frequency
and the severity of these impacts through Likert scales.
For each performance a score is calculated by multiplying
the frequency and severity scores. The sum of these
performances scores is divided by the maximum possible
score and multiplied by 100 to give a percentage overall
score. In addition, the OIDP extent was calculated as the
number of performances affected [21,22].
For both the OHIP-14 and the OIDP, a higher score
indicates worse OHRQoL. The recall period for both
was changed from the usual 12 or 6 months to 1 month
in patients and controls. As cases were interviewed at
least 6 months after the end of their oral cancer treatment,
we used a 1-month time reference in order to avoid
including the acute period of recovery, in the cases of
recent treatment.Statistical analysis
Statistical analysis was performed using the SPSS version
17.0 software package (SPSS Inc., Chicago, IL). Descriptive
analysis of socio-demographic variables, SF-12, OHIP and
OIDP was followed by bivariate associations between the
covariates and study group (patients or controls) using
the appropriate test according to the type of variable
(chi squared for categorical variables, t-test for continuous
normally distributed and Mann–Whitney for continuous
skewed variables).Linear regression models evaluated the differences in
the summary components of SF-12 between patients and
controls. Because the OHRQoL outcome variables were
not normally distributed in our sample, we evaluated the
unadjusted and adjusted associations of OHIP-14 and
OIDP with the study group (patients versus controls)
using ordinal multimodal regression models. The OHIP-14
extent and OIDP extent were categorized as the dependent
variables (0 = 0 items affected; 1 = 1–2 items affected;
2 = 3–4 items affected and 3 = 5 or more items
affected). The first adjusted model accounted for the
effect of all socio-demographic variables (age, gender
and social class). We sequentially added the only oral
health variable that was significant in the bivariate model
(posterior functional teeth) to construct the second
adjusted model and the final model was built by
additionally accounting for the effect of general health
(presence of illness).
Possible differences in outcome variables (SF-12, OHIP
and OIDP) with respect to the origin of controls (social
centers versus geriatric centers versus companions of
hospital patients) were evaluated with Kruskal-Wallis
and ANOVA test.
Bivariate associations between clinical and treatment data
of the patients were evaluated using the appropriate test
according to the type of variable (t-test and ANOVA test
for continuous normally distributed and Mann–Whitney
test and Kruskal Wallis test for continuous skewed
variables).
The level of statistical significant was set to p < 0.05.
Furthermore, to assess the clinical importance of the
difference in HRQoL and OHRQoL between patients
and controls we calculated the standardized effect size
[23] for SF-12, OHIP-14 and OIDP.
Authors have followed the STROBE guidelines for
carrying out the study and for writing the paper [24].
Results
The descriptive data and bivariate associations between
study group and socio-economic variables are shown in
Table 1. Overall, 64.1% were males. The mean age was
65.2 (standard deviation (sd): 12.9) years in patients and
67.5 (sd: 13.7) years in controls. More than half of the
patients and controls belonged in the lowest social class
(V). No significant differences were found between these
two groups with respect to the sociodemographic
data or the presence of diseases. The patients had
significantly fewer posterior functional tooth units
compared to the controls.
The most frequent location for oral cancer was the
tongue and the clinical stages I and IV were the more
prevalent. The mean follow-up was 4.9 (sd: 4.3) years
and the most common treatment was surgery without
adjuvant radiotherapy and/or chemotherapy.
Table 1 Socio-economic and clinical data variables
description of oral cancer survivors and controls
Variable Patients Controls p
n (%) n (%)
All 142 (100) 142 (100)
Sex 1.000a
Male 91 (64.1) 91 (64.1)
Age (years)
<50 18 (12.7) 18 (12.7)
50-65 54 (38.0) 54 (38.0)
>65 70 (49.3) 70 (49.3)
range 29-90 26-93
mean ± sd 65.2 ± 12.9 67.5 ± 13.7 0.151b
Social Classd 0.790c
I 8 (5.6) 8 (5.6)
II 8 (5.6) 9 (6.3)
III 14 (9.9) 8 (5.6)
IV 35 (24.6) 45 (31.7)
V 77 (54.2) 72 (50.7)
Functional tooth units
Anterior (mean ± sd) 2.4 ± 2.7 3.0 ± 2.7 0.072b
Posterior (mean ± sd) 2.4 ± 3.6 3.9 ± 4.5 0.004b
Presence of diseasese 0.886c
No 29 (20.4) 30 (21.1)
1 57 (40.1) 53 (37.3)
2 ó more 56 (39.5) 59 (41.6)
Tumor site
Tongue 50 (35.2)
Buccal mucosa 18 (12.7)













Table 1 Socio-economic and clinical data variables
description of oral cancer survivors and controls
(Continued)
Mean ± sd 4.9 ± 4.3
Treatment
Sf 74 (52.1)
S + RTg 43 (30.3)
S + RT + CHh 25 (17.6)
achi-square test with Yates continuity correction; bStudent’s t test;
cMann–Whitney test; dIn descending order; eChronic diseases; fS: surgery;
gRT: radiotherapy; hCH: chemotherapy.
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patients and controls were found in the following
dimensions: Role Physical, Bodily Pain and General
Health. Patients had significant worse Physical component
summary. These differences were not significant in
Physical functioning, Vitality, Social Functioning, Role
Emotional, Mental Health dimensions and in the Mental
component summary (Table 2).
In terms of the OHRQoL, there were statistically
significant differences between patients and controls
in all the domains or items and in the overall score
of both questionnaires. The largest differences were
in physical disability, physical pain and functional
limitation in the OHIP-14 and in speaking, eating and
emotional status in the OIDP. The domains/performances
with highest score (worse impact) were similar for both
groups (patients and controls); these referred to physical
pain for the OHIP-14 and eating difficulty for the OIDP
(Table 3).
There were no statistically significant differences in
any outcome variables regarding to the origin of controls
(data no shown).Table 2 Comparison of health-related quality of life
(SF-12) between oral cancer survivors (n = 142) and
controls (n = 142)
Variable Cases Controls pa
Mean ± sd Mean ± sd
Physical functioning 41.2 ± 13.0 42.7 ± 12.2 0.295
Role physical 40.7 ± 13.0 44.6 ± 12.0 0.009
Bodily pain 46.4 ± 9.2 50.0 ± 7.0 <0.001
General health 44.0 ± 6.2 45.9 ± 7.9 0.023
Vitality 45.4 ± 7.9 46.6 ± 8.6 0.227
Social functioning 43.0 ± 12.5 45.6 ± 9.6 0.055
Role emotional 44.7 ± 12.6 47.2 ± 10.0 0.063
Mental health 44.8 ± 8.9 45.1 ± 7.9 0.732
Physical component summaryb 42.2 ± 12.0 45.5 ± 11.2 0.019
Mental component summaryc 45.8 ± 11.6 46.6 ± 8.9 0.509
aStudent’s t test; bThe effect size of the difference was 0.28 (95% CI:
0.05-0.51); cThe effect size of the difference was 0.08 (95% CI: −0.15-0.31).
Table 3 Comparison of oral health-related quality of life
(OHIP-14 and OIDP) between oral cancer survivors
(n = 142) and controls (n = 142)
Variable Cases Controls pa
Mean ± sd Mean ± sd
OHIP-14b,c
Functional limitation 3.3 ± 2.2 1.4 ± 2.1 <0.001
Physical pain 3.9 ± 2.4 1.8 ± 1.9 <0.001
Psychologycal discomfort 2.7 ± 2.5 0.6 ± 1.2 <0.001
Physical disability 3.7 ± 2.9 1.5 ± 2.1 <0.001
Mental disability 1.6 ± 2.2 0.2 ± 0.9 <0.001
Social disability 1.6 ± 2.2 0.1 ± 0.5 <0.001
Handicap 2.1 ± 2.1 0.3 ± 0.7 <0.001
Overall 18.9 ± 11.8 5.9 ± 6.2 <0.001
OIDPd,e
Eating 9.8 ± 7.2 3.9 ± 4.8 <0.001
Speaking 7.8 ± 6.5 0.7 ± 1.8 <0.001
Cleaning teeth 1.1 ± 3.3 0.1 ± 0.8 <0.001
Physical activities 2.4 ± 4.7 0.1 ± 0.7 <0.001
Social contact 3.8 ± 6.2 0.2 ± 1.4 <0.001
Sleeping 2.8 ± 4.6 0.2 ± 0.9 <0.001
Smiling 2.3 ± 5.0 0.8 ± 2.3 0.001
Emotional status 6.4 ± 6.9 0.9 ± 2.1 <0.001
Overall 22.9 ± 18.3 4.3 ± 5.5 <0.001
aStudent’s t test; bOHIP-14: Oral Health Impact Profile; cthe effect size of the
difference was 1.38 (95% CI: 1.12-1.64); dOIDP: Oral Impacts on Daily
Performances; ethe effect size of the difference was 1.38 (95% CI: 1.12-1.64).
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Patients had worse Physical Component Summary
scores than controls in the unadjusted model. This
relationship remained significant in all the adjusted
models [β-coefficient = −0.11 (95% CI: − (−5.12)-(−0.16)
in the fully adjusted model]. Conversely, the differences in
Mental Component Summary between patients and
controls were not statistically significant in none of
the models. There were significant differences between the
two groups in OHRQoL. Patients had worse OHRQoL than
controls. Patients had 11.63 (95% CI: 6.77-20.01) higher
odds for the OHIP-14 and 21.26 (95% CI: 11.54-39.13)Table 4 Multiple regression analysis: PCSc, MCSd, OHIP-14f an
1:Crude 2: Model 1 + Age + gender + soci
βa [95% CI] p-value β [95% CI] p-valu
PCSb, c −3.24 [−5.95-(−0.53)] 0.019 −3.87 [−6.40-(−1.33)] 0.003
MCSb,d −0.81 [−3.22-1.60] 0.509 −0.75 [−3.18-1.69] 0.547
OHIPe,f 10.62 [6.30-17.90] <0.001 11.44 [6.69-19.55] <0.001
OIDPe,g 18.82 [10.37-34.15] <0.001 21.07 [11.48-38.63] <0.001
aDifferences between oral cancer survivors (n = 142) and controls (n = 142); bLinear
Summary; eOrdinal logistic regression; fOHIP: Oral Health Impact Profile; gOIDP: Oralhigher odds for OIDP of being in a worse category (higher
number of performances impaired) of OHRQoL compared
to controls in the fully adjusted model. Regarding the
clinical importance, the effect sizes of the differences in
OHRQoL between patients and controls were 1.38 for
the OHIP-14 (95% CI: 1.12-1.64) and 1.38 for the OIDP
(95% CI: 1.12-1.64) (note that calculations arrived
to exactly the same 95%-CIs for the OHIP and the OIDP
although they come from different figures). The respect-
ive effect sizes in HRQoL were 0.28 (95% CI: 0.05-0.51)
in the Physical Component Summary and 0.08
(95% CI: −0.15-0.31) in the Mental Component Sum-
mary score.
Table 5 shows the bivariate associations between
clinical and treatment data and HRQoL and OHRQoL
in patients treated for oral cancer. There were statistically
significant differences in the OHRQoL according to the
clinical stage and type of treatment. Patients in early
stages of oral cancer had better OHRQoL compared to
patients with oral cancer in advanced clinical stages.
Patients who received only surgical treatment obtained
better scores in the OHRQoL than those that received
combined treatment (surgery and radiotherapy and/or
chemotherapy).
Discussion
This study showed that patients treated for oral or
oropharyngeal cancer experienced significantly worse
physical domains of HRQoL and OHRQoL compared
to the general population even after adjusting for the
effect of sociodemographic characteristics, oral health
and general health. These differences were moderate
for the physical domains of HRQoL and severe for
OHRQoL. On the other hand, the results suggest that
there could be a psychological adaptation over time
in these patients.
Generic HRQoL measures have been widely used to
compare general and patient populations, estimate the
burden of disease and provide information on the
effectiveness of treatments and health care [17]. The
particularity of the SF-12 is that its standardized
scores permit direct interpretation compared to the
Spanish population norms, the reference population ind OIDPg as dependent variables
al class 3: Model 2 + PFT 4: Model 3 + Illness
e β [95% CI] p-value β [95% CI] p-value
−2.66 [−5.18-(−0.13)] 0.039 −2.60 [−5.10-(−0.11)] 0.041
−0.78 [−3.28-1.72] 0.541 −0.77 [−3.27-1.74] 0.547
11.78 [6.86-20.21] <0.001 11.63 [6.77-20.01] <0.001
21.14 [11.52-38.82] <0.001 21.26 [11.54-39.13] <0.001
regression; cPCS: Physical Component Summary; dMCS: Mental Component
Impacts on Daily Performances.
Table 5 Association between clinical and treatment data and health-related quality of life and oral health-related qual-
ity of life in patients survivors of oral cancer (n = 142)
Variable PCSa MCSb OHIP-14c OIDPd
Mean ± de Mean ± de Mean ± de Mean ± de
Location
Oral 47.5 ± 11.6 36.9 ± 9.0 18.3 ± 11.9 22.1 ± 18.0
Oropharynx 46.5 ± 10.5 35.4 ± 9.0 23.7 ± 9.8 28.7 ± 20.3
pe = 0.730 pe = 0.520 pg = 0.043 pg = 0.155
Clinical stage
I-II 49.1 ± 11.9 36.5 ± 10.0 14.8 ± 10.3 17.0 ± 15.7
III-IV 46.2 ± 11.0 36.1 ± 8.1 22.0 ± 11.9 27.4 ± 19.0
pe = 0.133 pe = 0.768 pg = <0.001 pg = <0.001
Follow-up (years)
0.5-5 41.5 ± 1.3 46.0 ± 1.2 19.5 ± 1.3 23.4 ± 1.9
6-10 43.5 ± 2.1 44.7 ± 2.3 16.5 ± 1.7 20.1 ± 2.7
11-20 43.7 ± 2.8 47.0 ± 2.2 20.8 ± 3.2 25.6 ± 5.8
pf = 0.614 pf = 0.780 ph = 0.454 ph = 0.743
Treatment
Surgery 47.5 ± 12.1 36.7 ± 9.6 16.1 ± 11.6 19.0 ± 18.4
Combined treatment 47.3 ± 10.8 36.8 ± 8.2 22.0 ± 11.3 26.7 ± 17.6
pe = 0.897 pe = 0.950 pg = 0.002 pg = 0.002
aPCS: Physical Component Summary; bMCS: Mental Component Summary; cOHIP-14: Oral Health Impact Profile; dOIDP: Oral Impacts on Daily Performances;
eStudent’s t test; fANOVA test; gMann–Whitney U test; hKruskal Wallis test.
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scores in all the SF-12 domains compared to the Spanish
population norms [16]. This finding is similar to that
found in the study of Fang et al. [8]. Comparing to the
control group, we found that the mean scores of the eight
functional domains and summary components of the SF
were lower for patients, being statistically significant in
the Role Physical, Bodily Pain, General Health in our
study. These findings contrast with those found in other
studies [10-13] where some domains as General Health or
Vitality were better in the patients than the reference
group. These disagreements could be explained because of
using population norms rather than a control group
or doing the evaluations at a different period after
the treatment. In fact, it is difficult to know at when
exactly the quality of life of patients treated for oral
cancer improves [4].
The differences in Physical functioning between patients
and controls were not statistically significant in our study.
Maybe this could be because the items of this dimension
refer to activities that require moderate efforts. There
were statistically significant differences between patients
and controls in the Role Physical and in the Physical
component summary (even after adjusting this last
variable for age, gender, social class, posterior functional
teeth and illness). These differences are clinically relevant:
effect sizes of the differences in SF-12 Physical componentsummary between patients and controls were moderate,
according to the benchmarks suggested by Cohen’s stand-
ard criteria [14]. The SF-12 Physical component summary
has been showed to be predictive of long-term survival in
patients with head and neck cancer. A gradual increase of
physical activity in these patients might have a positive
impact in physical and functional domains and, in turn,
the rates of overall mortality could improve [25,26].
The SF-12 Mental component summary scores are
very similar in patients and controls. While it seems
logical to expect that patients treated for oral cancer
have considerable psychological impacts, research has
shown that this is not necessarily the case [11]. Individual
attitudes are modified by expectations and adaptation to
the condition [27] and specifically, in oral cancer patients,
they can also be influenced by coping and fear of recurrence
[28,29]. Our patients were evaluated at least 6 months after
treatment which could be sufficient for allowing patients
time to adapt to their new situation. Moreover, patients
had similar scores in Role Emotional and Social
functioning to the controls in our sample; people with
high scores on these domains are more likely to report
better life satisfaction [11].
Despite the time elapsed since treatment and in line
with the study of Hassel et al. [9], OHRQoL was signifi-
cantly worse in patients than controls. The most important
differences, both in OHIP-14 and OIDP, were found in
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study by Linsen et al. [30], and speaking. Problems eating
could be directly linked to the frequent reports of difficulty
chewing and swallowing in patients treated for oral cancer
[4,31,32]. On the other hand, the problem with speaking
could be due to restriction in tongue mobility (the
most frequent location of oral cancer in our sample).
It can result in speech incomprehension and is highly
correlated with patient’s quality of life [33]. These dif-
ferences between patients and controls should not be
underestimated as the very large effects sizes (both
for OHIP and OIDP) highlighted their clinical importance.
The aforementioned consequences would improve if pre-
ventive rehabilitation programs were routinely established
for these patients [34-36].
Looking at the clinical characteristics of the oral
cancer patients, we showed that combined therapy (as
opposed to only surgical treatment) and advanced
(compared to early) clinical stages of oral cancer
adversely affected the OHRQoL of the patients. These
results agree with those found in previous studies
[37-39]. There is no consensus in the literature about
whether the location of the tumor affects the quality
of life [39]. In our study, it was a variable significantly
associated with OHRQoL evaluated with the OHIP-14;
oropharyngeal cancer patients had worse OHRQoL than
oral cancer patients. Finally, the follow-up period was not
significantly associated with any of these parameters. This
finding together with the results of other studies showing
improvements in quality of life after a year [40],
three years [37] or five years [10,12,13], suggest that
the literature is inconclusive about a specific follow-up
period associated with improved HRQOL or OHRQoL
and also imply that the pattern of improvement over time
may not be linear.
This study has some limitations. First, there is not
relevant data available to allow comparisons with pre-
treatment scores, which would have shown to what
extent our results reflect the long-term adaptation of
patients after treatment. We have attempted to partly
address this by including a control group in order to
compare estimates between this and the group that re-
ceived treatment. We also used both generic HRQoL
and OHRQoL questionnaires, but their use does not rule
out the possibility that the observed impacts in patients
may be due to other oral conditions, not just due to oral
cancer or its treatment. This could have been addressed
through the additional use of cancer-specific HRQoL
and OHRQoL measures and these should be included in
future research. Second, we also acknowledge that the
heterogeneity in terms of the follow-up period for the
patients treated with cancer may not be suitable for de-
termining critical time periods for evaluation of quality
of life [13]. However, this variety in the follow-up periodreflects more accurately what actually happens with the
population of oral cancer patients and therefore our re-
sults are more representative of the perceptions and ex-
periences of patients surviving from oral cancer. A third
limitation relates to the selection of controls. We did
not undertake a random selection of the base population
but this is acceptable practice when the base population
is difficult to identify. In addition, we employed meth-
odological features to account for potential limitations
linked to selection of controls. We matched for sex and
age in order to minimize confounding and further tested
this in the bivariate analysis. Moreover, there were no
differences in the outcomes with respect to the origin of
controls. The information was collected in the same way
in cases and controls (comparable accuracy) and we re-
cruited a relatively large sample with the same number
of controls and cases which allowed us to achieve the
objectives of the study (efficiency).
Conclusion
This study indicated that oral cancer patients had worse
OHRQoL and worse scores in physical dimensions of
HRQoL than the general population at least 6 months
after treatment. Conversely, they were similar to the gen-
eral population in overall psychological dimensions of
HRQoL, possibly due to psychological adaptation to their
condition. Implemention of rehabilitation programs could
benefit and improve the quality of life of these patients.
Abbreviations
HRQoL: Health-related quality of life; OHRQoL: Oral health-related quality of
life; SF-12: The 12-item short form health survey; OHIP-14: Oral health impact
profile; OIDP: Oral impacts on daily performances.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RB carried out the study and drafted the manuscript. GT and MB conceived
and coordinated the study from its design to the manuscript confection.
JAGM, IML and BM made contributions to the conception, design, data
analysis and interpretation. All authors read and approved the final
manuscript.
Acknowledgements
Rocio Barrios, academic training, is being supported by the postgraduate
research fellowship “Programa de Formación del Profesorado Universitario”
from the Spanish Ministry of Education, Culture and Sport. This study was
also supported by the Andalusian Research Group CTS-503.
Author details
1Research Fellow of the Spanish Ministry of Education, School of Dentistry,
University of Granada, c/Llanete del Mercado n 5, 23680 Alcalá la Real, Jaen,
Spain. 2Preventive and Community Dentistry, School of Dentistry, University
of Granada, C/Campus Cartuja s/n, 18071 Granada, Spain. 3Special Care in
Dentistry and Gerodontology, School of Dentistry, University of Granada,
C/Campus Cartuja s/n, 18071 Granada, Spain. 4Oral and Maxillofacial Surgeon,
Servicio de Cirugía Maxilofacial, Hospital Universitario “Virgen de las Nieves”,
Avenida de las Fuerzas Armadas, 2, 18014 Granada, Spain. 5Department of
Epidemiology and Public Health, Dental Public Health, Institute of
Epidemiology and Health, University College London, 1-19 Torrington Place,
London WC1E6BT, UK.
Barrios et al. Health and Quality of Life Outcomes  (2015) 13:9 Page 8 of 8Received: 16 October 2014 Accepted: 23 December 2014References
1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin.
2014;64:9–29.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer
statistics. CA Cancer J Clin. 2011;61:69–90.
3. Rogers SN. Quality of life perspectives in patients with oral cancer. Oral
Oncol. 2010;46:445–7.
4. Torres-Carranza E, Infante-Cossío P, Hernández-Guisado JM, Hens-Aumente
E, Gutierrez-Pérez JL. Assessment of quality of life in oral cancer. Med Oral
Pat Oral Cir Bucal. 2008;13:735–41.
5. D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and
functional status measures in patients with head and neck cancer. Arch
Otolaryngol Head Neck Surg. 1996;122:482–7.
6. Sischo L, Broder HL. Oral health-related quality of life: what, why, how, and
future implications. J Dent Res. 2011;90:1264–70.
7. Sherman AC, Simonton S. Advances in quality of life research among head
and neck cancer patients. Curr Oncol Rep. 2010;12:208–15.
8. Fang FM, Tsai WL, Chien CY, Chiu HC, Wang CJ. Health-related quality of life
outcome for oral cancer survivors after surgery and postoperative radiotherapy.
Jpn J Clin. 2004;34:641–6.
9. Hassel AJ, Danner D, Freier K, Hofele C, Becker-Bikowski K, Engel M. Oral
health-related quality of life and depression/anxiety in long-term
recurrence-free patients after treatment for advanced oral squamous cell
cancer. J Craniomaxillofac Surg. 2012;40:99–102.
10. Herce J, Rollón A, Polo J. Quality of life in long-term oral cancer survivors
and comparison with reference values of Spanish people. Med Clin (Barc).
2007;128:692–6.
11. Llewellyn CD, Weinman J, McGurk M. A cross-sectional comparison study of
cognitive and emotional well-being in oral cancer patients. Oral Oncol.
2008;44:124–32.
12. Herce J, Rollón A, Lozano R, Salazar C, Gallana S. Quality of life in long-term
oral cancer survivors: a comparison with Spanish general population norms.
J Oral Maxillofac Surg. 2009;67:1607–14.
13. Herce-Lopez J, Rollon-Mayordomo A, Lozano-Rosado R, Infante-Cossio P,
Salazar-Fernandez CI. Assesment of quality of life of oral cancer survivors
compared with Spanish population norms. Int J Oral Maxillofac Surg.
2013;42:446–52.
14. Cohen J. Statistical power analysis for the behavioural sciences. 2nd ed.
New Jersey: Lawrence Erlbaum; 1988.
15. Hatch JP, Shinkai RS, Sakai S, Rugh JD, Paunovich ED. Determinants of
masticatory performance in dentate adults. Arch Oral Biol. 2001;46:641–8.
16. Schmidt S, Vilagut G, Garin O, Cunillera O, Tresserras R, Brugulat P, et al.
Reference guidelines for the 12-item short-form health survey version 2
based on the catalan general population. Med Clin (Barc). 2012;139:613–25.
17. Brazier JE, Roberts J. The estimation of a preference-based measure of
health from the SF-12. Med Care. 2004;42:851–9.
18. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al.
Cross-validation of item selection and scoring for the SF-12 health survey in
nine countries: results from the IQOLA project. international quality of life
assessment. J Clin Epidemiol. 1998;51:1171–8.
19. Ware JE, Kosinski Jr M, Turner-Bowker DM, Gandek B. How to score version
2 of the SF 12 health survey (with a supplement documenting version 1).
Lincoln, RI: QualityMetric, Inc.; 2002.
20. Montero-Martín J, Bravo-Pérez M, Albaladejo-Martínez A, Hernández-Martín
LA, Rosel-Gallardo EM. Validation the Oral Health Impact Profile (OHIP-14sp)
for adults in Spain. Med Oral Patol Oral Cir Bucal. 2009;14:44–50.
21. Montero J, Bravo M, Albaladejo A. Validation of two complementary oral-health
related quality of life indicators (OIDP and OSS 0–10) in two qualitatively distinct
samples of the Spanish population. Health Qual Life Outcomes. 2008;6:101.
22. Gherunpong S, Tsakos G, Sheiham A. The prevalence and severity of oral
impacts on daily performances in Thai primary school children. Health Qual
Life Outcomes. 2004;2:57.
23. Viechtbauer W. Approximate confidence intervals for standardized effect
sizes in the two-independent and two-dependent samples design. J Educ
Behav Stat. 2007;32:39–60.
24. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke
JP. STROBE initiative the Strengthening the Reporting of ObservationalStudies in Epidemiology (STROBE) statement: guidelines for reporting
observational studies. J Clin Epidemiol. 2008;61:344–9.
25. Grignon LM, Jameson MJ, Karnell LH, Christensen AJ, Funk GF. General
health measures and long-term survival in patients with head and neck
cancer. Arch Otolaryngol Head Neck Surg. 2007;133:471–6.
26. Sammut L, Ward M, Patel N. Physical activity and quality of life in head and
neck cancer survivors: a literature review. Int J Sport Med. 2014;35:794–9.
27. Allen PF. Assessment of oral health related quality of life. Health Qual Life
Outcomes. 2003;8:1–40.
28. Handschel J, Naujoks C, Kübler NR, Krüskemper G. Fear of recurrence
significantly influences quality of life in oral cancer patients. Oral Oncol.
2012;48:1276–80.
29. Hassanein KA, Musgrove BT, Bradbury E. Functional status of patients with
oral cancer and its relation to style of coping, social support and
psychological status. Br J Oral Maxillofac Surg. 2011;39:340–5.
30. Linsen S, Schmidt-Beer U, Fimmers R, Gruner M, Koeck B. Craniomandibular
pain, bite force, and oral health-related quality of life in patients with jaw
resection. J Pain Symptom Manage. 2009;37:94–106.
31. Biazevic MG, Antunes JL, Togni J, de Andrade FP, de Carvalho MB, Wünsch-Filho V.
Survival and quality of life of patients with oral and oropharyngeal cancer at 1-year
follow-up of tumor resection. J Appl Oral Sci. 2010;18:279–84.
32. Dwivedi RC, Chisholm EJ, Khan AS, Harris NJ, Bhide SA, St Rose S, et al. An
exploratory study of the influence of clinical-demographic variables on swallowing
and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer
patients treated with primary surgery. Eur Arch Otorhinolaryngol. 2012;269:1233–9.
33. Schuster M, Stelzle F. Outcome measurements after oral cancer treatment:
speech-related aspects—an overview. Oral Maxillofac Surg. 2012;16:291–8.
34. Cnossen IC, van Uden-Kraan CF, Rinkel R, Aalders IJ, de Goede C, de Bree R,
et al. Multimodal guided self-help exercise program to prevent speech,
swallowing, and shoulder problems among head and neck cancer patients:
a feasibility study. J Med Internet Res. 2014;16:e74.
35. Zhen Y, Wang JG, Tao D, Wang HJ, Chen WL. Efficacy survey of swallowing
function and quality of life in response to therapeutic intervention
following rehabilitation treatment in dysphagic tongue cancer patients. Eur
J Oncol Nurs. 2012;16:54–8.
36. Guru K, Manoor UK, Supe SS. A comprehensive review of head and neck
cancer rehabilitation: physical therapy perspectives. Indian J Palliat Care.
2012;18:87–97.
37. Infante-Cossio P, Torres-Carranza E, Cayuela A, Hens-Aumente E, Pastor-
Gaitan P, Gutierrez-Perez JL. Impact of treatment on quality of life for oral
and oropharyngeal carcinoma. Int J Oral Maxillofac Surg. 2009;38:1052–8.
38. Gurney TA, Eisele DW, Orloff LA, Wang SF. Predictors of quality of life after
treatment for oral cavity and oropharyngeal carcinoma. Otolaryngol Head
Neck Surg. 2008;139:262–7.
39. Chandu A, Smith AC, Rogers SN. Health-related quality of life in oral cancer:
a review. J Oral Maxillofac Surg. 2006;64:495–502.
40. Barrios R, Montero J, González-Moles MA, Baca P, Bravo M. Levels of
scientific evidence of the quality of life in patients treated for oral cancer.
Med Oral Patol Oral Cir Bucal. 2013;18:e578–84.
